Atlas Trials

A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects

Clinical trial NCT03748745 · COMPLETED

Trial details

NCT number
NCT03748745
Sponsor
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Interactions
Start date
2018-11-19
Primary completion
2018-12-25
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.